3.8 Review

Prevention vs treatment of rheumatoid arthritis

Journal

IMMUNOTHERAPY ADVANCES
Volume 3, Issue 1, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/immadv/ltad016

Keywords

Prevention; Rheumatoid arthritis; Autoimmunity; Tolerance; Immunotherapy

Categories

Ask authors/readers for more resources

In the case of rheumatoid arthritis, the focus has mostly been on treating the established disease rather than preventing it. This review argues that prevention should become a major part of research and clinical practice, and describes the basis for broad public health-based prevention as well as a precision prevention strategy for individuals at high risk. The potential effectiveness of precision prevention will depend on the development of specific and long-lasting tolerance therapy.
Whether a yet chronic and not curable disease like rheumatoid arthritis (RA) can be subject to prevention or whether available resources should be focused on treatment is a classical dilemma. Similar to the case in most other chronic diseases, the focus in research as well as in clinical practice has been on the treatment of established diseases, resulting in drugs that are efficient in eliminating most joint damage but not able to cure the disease or stop needs for continuous treatment of the disease. Less effort has been spent on identifying and implementing ways to prevent the disease. We argue in this review that knowledge concerning the longitudinal evolvement of the major, 'seropositive' subset of RA has now come to a stage where prevention should be a large part of the research agenda and that we should prepare for prevention as part of clinical practice in RA. We describe briefly the knowledge basis for broad public health-based prevention as well as for a 'precision prevention' strategy. In the latter, individuals at high risk for RA will be identified, monitored, and ultimately provided with advice on how to change lifestyle/environment or be given treatment with drugs able to delay and ultimately stop the development of RA. Whether this potential of precision prevention for RA will change the broader clinical practice will depend on whether specific and long-lasting interference with disease-inducing immunity, ultimately 'tolerance therapy', will become a reality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available